May 18, 2022: Our 17th healthcare database profile from Japan
The PatientsMap is a longitudinal, cross-sectional physician-survey database capturing the patient population size of 1,000 conditions in major countries including Japan, since 2011.
PatientsMap (Japan)
Database Contact Data
Email: patientsmap@ssri.com
Alternate Contact
Social Survey Research Information (SSRI)
Please complete the contact form at: https://www.ssri.com/e/contact_us
References of Studies Using/Describing Database
Please visit https://research.ssri.co.jp/pmap/pastdata
May 16, 2022 – Need help with a database-related project?
The B.R.I.D.G.E. TO DATA® team offers assistance on database-related projects, including database landscaping. Some examples of how the team can help your studies succeed include:
May 9, 2022 – Unsure of a coding system, term, or field description?
Subscribers have access to B.R.I.D.G.E. TO DATA’s proprietary glossary. This list contains definitions of all our 135 Database Fields, as well as all the coding systems used in our profiles. This glossary is continuously updated each time we come across something new regarding a database, as summarized in our profiles.
May 2, 2022 – For a overview of B.R.I.D.G.E. TO DATA®…
Download our latest trifold brochure, then share it with colleagues and friends. Contact us for more information.
Apr 18, 2022 – B.R.I.D.G.E. TO DATA in research
B.R.I.D.G.E. TO DATA has been utilized in several published studies and cited in relevant textbooks and presentations.
We are also listed on prominent industry websites such as the Drug Safety Research Unit (DSRU), International Society for Pharmacoepidemiology (ISPE), and PsoBest.
Check out the list of citations and website mentions
Apr 14, 2022 – View our latest newsletter
In today’s newsletter you can read all about our latest website enhancements, updated tutorial videos, new profiles recently added, and a special spring subscription offer Click here to read more!
Apr 11, 2022 – Three new Israeli profiles added from the Maccabi Healthcare Services (MHS).
We are pleased to add these three MHS profiles to our compendium:
Maccabi Healthcare Services (MHS) HCV Registry (Israel)
Database Contact Data
Adi Rennert
Business Development
Database Research Services
27 Hamered St., 4th floor
Tel Aviv 68125
ISRAEL
Phone: +972-3-514-3755
Fax: +972-3-795-2612
Email: Rennert_a@mac.org.il
Alternate Contact
Dr. Asaf Peretz, MD, MBA
Head, Drug Repurposing – Maccabitech
Maccabi Research & Innovation Center
27 Hamered St.
Tel Aviv 68125
ISRAEL
Phone: +972-52-4209831
Email: peretz_as@mac.org.il
References of Studies Using/Describing Database
1. Cornberg M, Ahumada A, Aghemo A, Andreoni M, Bhagat A, Butrymowicz I, Carmiel M, Chodick G, Conway B, Song Y, Gasbarrini A, Hüppe D, Plaza FJ, Lampertico P, Alonso MLM, Myles L, Persico M, Ramji A, Sarrazin C, Villa E, Weil C, Otano JIU; CREST Study Group. Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study. Adv Ther. 2022 Jul;39(7):3146-3158.
2. Weil C, Mehta D, Koren G, Pinsky B, Samp JC, Chodick G, Shalev V. Sustained virological response to ombitasvir/paritaprevir/ritonavir and dasabuvir treatment for hepatitis C: Real-world data from a large healthcare provider. J Viral Hepat. 2018 Feb;25(2):144-151.
3. Weil C, Nwankwo C, Friedman M, Kenet G, Chodick G, Shalev V. Epidemiology of hepatitis C virus infection in a large Israeli health maintenance organization. J Med Virol. 2016 Jun;88(6):1044-50.
4. Weil C, Nwankwo C, Friedman M, Shalev V, Chodick G. Real-World Data on Multiple Comorbidities Among Patients With Hepatitis C: Considerations for Patient Care And Prognosis. VOLUME 18, ISSUE 7, PA543, NOVEMBER 01, 2015. Value Health/ISPOR - Open Archive DOI:https://doi.org/10.1016/j.jval.2015.09.1723.